Estimating the Value of Adding 30 Days to the 180-Day Market Exclusivity of the First-to-File Generic Drug Manufacturer.
Saved in:
| Title: | Estimating the Value of Adding 30 Days to the 180-Day Market Exclusivity of the First-to-File Generic Drug Manufacturer. |
|---|---|
| Authors: | Sertkaya, Aylin1 (AUTHOR) aylin.sertkaya@erg.com, El-Kilani, Zeid2 (AUTHOR), Klein, Sean3 (AUTHOR), Lord, Andreas1 (AUTHOR), Jacobo-Rubio, Ruben4 (AUTHOR), Parasrampuria, Sonal3 (AUTHOR) |
| Source: | PharmacoEconomics - Open. Jan2026, Vol. 10 Issue 1, p143-152. 10p. |
| Database: | Business Source Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 25094254 |
|---|---|
| DOI: | 10.1007/s41669-025-00607-w |
